1 |
À¯ÀüÀÚ ¹× »ý¹°ÇÐÀû Ȱ¼º ¾à¹°À» ¼¼Æ÷³»·Î È¿°úÀûÀ¸·Î Àü´ÞÇÏ´Â À¯Á¦ ¹× ±×°ÍÀÇ Á¦Á¶¹æ¹ý |
ƯÇãÃâ¿ø
(10-1997-0003022) |
´ëÇѹα¹, 1997.01.31 |
2 |
Çü±¤ À̹Ì¡¹ýÀ» ÀÌ¿ëÇÑ £µ££È£Ô£¶ ¼ö¿ëü ¸®°£µå °íÈ¿À² °Ë»ö¹ý
(Cell-based high-throughput screening method of 5-HT6 receptors using fluorescence calcium imaging) |
ƯÇãÃâ¿ø
(10-2006-0064037)
ƯÇãµî·Ï
(10-0852284-0000) |
´ëÇѹα¹, 2006.07.07
2008.08.07 |
3 |
±×·¼¸°À» ÇÔÀ¯Çϴ ô¼ö ¼Õ»ó Ä¡·á¿ë ¾àÇÐÀû Á¶¼º¹°
(Pharmaceutical composition comprising the ghrelin for treating injury of spinal cord) |
ƯÇãÃâ¿ø
(10-2008-0002098)
ƯÇãµî·Ï
(10-0977625-0000) |
´ëÇѹα¹, 2008.01.08
2010.08.17 |
4 |
¹éÁö ÃßÃâ¹°À» À¯È¿¼ººÐÀ¸·Î ÇÔÀ¯Çϴ ô¼ö¼Õ»ó Ä¡·á¿ë Á¶¼º¹°
(Composition for treating of injury of spinal cord containing extract of Angelica dahurica as an effective ingredient) |
ƯÇãÃâ¿ø
(10-2010-0012979)
ƯÇãµî·Ï
(10-1085082-0000) |
´ëÇѹα¹, 2010.02.11
2011.11.14 |
5 |
Áø¼¼³ë»çÀ̵å Rb1 ¹× Rg3, Compound K ¶Ç´Â ÀλïÀ¯·¡ »çÆ÷´Ñ ÃßÃâ¹°À» À¯È¿¼ººÐÀ¸·Î ÇÔÀ¯ÇÏ´Â ½Å°æº´Áõ¼º ÅëÁõ ¿¹¹æ ¹× Ä¡·á¿ë Á¶¼º¹°(Composition for preventing and treating of neuropathic pain containing ginsenoside Rb1 and Rg3, Compound K, or saponin extract from Panax ginseng as an effective ingredient) |
ƯÇãÃâ¿ø
(10-2011-0004037) |
´ëÇѹα¹, 2011.01.14
|
6 |
Ç÷ç¿Á¼¼Æ¾À» À¯È¿¼ººÐÀ¸·Î ÇÔÀ¯ÇÏ´Â ÁßÃ߽Űæ°è ÁúȯÀÇ ¿¹¹æ ¹× Ä¡·á¿ë ¾àÇÐÀû Á¶¼º¹°(Pharmaceutical composition comprising fluoxetine as an active ingredient for prevention or treatment of central nervous system diseases) |
ƯÇãÃâ¿ø
(10-2011-0106982)
ƯÇãµî·Ï
(10-1129303-0000) |
´ëÇѹα¹, 2011.10.19
2012.03.15 |